Elharam Ibrahim Abd allah, Abdel Rahim Mahmoud Muddathir*, Salah Eldin G. Elzaki, Wala Eldin Osman Elradi and Ream Elzain Abdelgadir


Background: Glutathione S-transferases (GSTs) are enzymes belong to phase II metabolic isozymes, best known for their ability of detoxification of xenobiotic. Several studies reported that gene Polymorphisms within GSTs family conferred a significant association with increased risk of CML. There is no published data about the association of gene polymorphism of these enzymes to CML Sudanese patient’s, So the present study aimed to find out if there was any association between GSTP1 gene polymorphism and CML in Sudanese patients. Materials and methods: This was case control study conducted between January 2016 and June 2017 in which a total of 115 patients with chronic myeloid leukaemia attended the Radiation and Isotope Centre-Khartoum and 104 un related apparently healthy individual as control group were involved. DNA extracted from collected EDTA venous blood samples and analysed by RFLP (Restriction fragments length polymorphism) to detect the presence of GSTP1 (Il105Val). Results: A total of 58.2% (67) of CML patients had heterozygous (Ile/Val) type of GSTP1 Ile105Val polymorphism, 4.35% (5) patients had the homozygous type (Val/ Val) and 37.3% (43) had the wild genotype of GSTP1 (Ile / Ile). In contrast there were 40.3% (42) of the control group with heterozygous (Ile/Val) type, 1.9% (2) with homozygous type (Val/ Val) and 57.6% (60) with wild genotype of GSTP1 (Ile / Ile). GSTP1 Ile105Val polymorphism frequency was found to be significantly elevated in patient with CML 62.6% (72) compared to control group 42.3% (44) (OR = 2.28, 95% confidence interval (CI) 1.33–3.91, p value = 0.002). Discussion and Conclusion: GSTP1 Ile105Val polymorphism was found to be significantly elevated in patient with CML and were associated with CML development and progression, also CML patients in advanced phase (accelerated and blast crisis) had higher frequency of GSTP1 Ile105Val polymorphism compared to chronic phase and this was agreed with most of the published studies.

Keywords: GSTP1: Glutathione S-transferase Pi, Ile105Val: Iso Lucin 105 Valin, CML: Chronic Myeloid Leukaemia.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MARCH 2024 Issue has been successfully launched on 1 MARCH 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction